biote Corp. (BTMD)
BTMD Stock Price Chart
Explore biote Corp. interactive price chart. Choose custom timeframes to analyze BTMD price movements and trends.
BTMD Company Profile
Discover essential business fundamentals and corporate details for biote Corp. (BTMD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
28 Apr 2021
Employees
217.00
Website
https://biote.comCEO
Bret Christensen
Description
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
BTMD Financial Timeline
Browse a chronological timeline of biote Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 10 Mar 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is $0.05.
Earnings released on 6 Aug 2025
EPS came in at $0.10 surpassing the estimated $0.06 by +66.67%, while revenue for the quarter reached $48.86M , beating expectations by +2.31%.
Earnings released on 7 May 2025
EPS came in at $0.08 surpassing the estimated $0.06 by +33.33%, while revenue for the quarter reached $48.99M , beating expectations by +3.69%.
Earnings released on 12 Mar 2025
EPS came in at $0.10 surpassing the estimated $0.09 by +11.11%, while revenue for the quarter reached $49.83M , missing expectations by -6.81%.
Earnings released on 12 Nov 2024
EPS came in at $0.33 surpassing the estimated $0.09 by +266.67%, while revenue for the quarter reached $51.38M , beating expectations by +0.37%.
Earnings released on 8 Aug 2024
EPS came in at $0.14 surpassing the estimated $0.09 by +55.56%, while revenue for the quarter reached $49.17M , missing expectations by -4.30%.
Earnings released on 7 May 2024
EPS came in at $0.23 surpassing the estimated $0.05 by +360.00%, while revenue for the quarter reached $46.80M , beating expectations by +2.47%.
Earnings released on 12 Mar 2024
EPS came in at $0.18 surpassing the estimated $0.08 by +125.00%, while revenue for the quarter reached $45.70M , missing expectations by -0.23%.
Earnings released on 7 Nov 2023
EPS came in at -$0.11 falling short of the estimated $0.08 by -237.50%, while revenue for the quarter reached $45.56M , missing expectations by -4.90%.
Earnings released on 10 Aug 2023
EPS came in at $0.44 surpassing the estimated $0.10 by +340.00%, while revenue for the quarter reached $49.26M , beating expectations by +5.33%.
Earnings released on 9 May 2023
EPS came in at $0.94 surpassing the estimated $0.09 by +944.44%, while revenue for the quarter reached $44.84M , beating expectations by +3.40%.
Earnings released on 28 Mar 2023
EPS came in at $0.18 surpassing the estimated $0.14 by +28.57%, while revenue for the quarter reached $44.49M , beating expectations by +1.49%.
Earnings released on 14 Nov 2022
EPS came in at -$0.09 falling short of the estimated $0.14 by -164.29%, while revenue for the quarter reached $41.97M , beating expectations by +0.01%.
Earnings released on 15 Aug 2022
EPS came in at $0.27 surpassing the estimated $0.14 by +92.86%, while revenue for the quarter reached $41.36M , beating expectations by +2.12%.
Earnings released on 21 May 2022
EPS came in at $1.23 , while revenue for the quarter reached $37.14M .
Earnings released on 7 Apr 2022
EPS came in at $0.72 , while revenue for the quarter reached $37.54M .
Earnings released on 24 Nov 2021
EPS came in at $1.13 , while revenue for the quarter reached $35.57M .
Earnings released on 17 Aug 2021
EPS came in at $1.29 , while revenue for the quarter reached $34.75M .
Earnings released on 20 May 2021
EPS came in at $9.02 , while revenue for the quarter reached $31.54M .
Earnings released on 3 Mar 2021
Earnings released on 31 Dec 2020
EPS came in at $9.65 , while revenue for the quarter reached $30.83M .
BTMD Stock Performance
Access detailed BTMD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.